Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017)

• Main Authors: Albert Y. Liu, Aliza Norwood, Holly Gundacker, Alex Carballo-Diéguez, Sherri Johnson, Karen Patterson, Linda Gail Bekker, Suwat Chariyalertsak, Anupong Chitwarakorn, Pedro Gonzales, Timothy H. Holtz, Kenneth H. Mayer, Carmen Zorrilla, Susan Buchbinder, Jeanna M. Piper, Javier R. Lama, Ross D. Cranston
• 格式: 雜誌
• 出版: 2019
• 主題: Medicine
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85069819169&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/65709

BACKGROUND: As daily oral preexposure prophylaxis (PrEP) becomes standard for HIV prevention, routine use of PrEP is likely to increase within clinical trials of novel preventive agents. We describe the prevalence and characteristics of participants reporting nonstudy oral PrEP use within Microbicid...